person

Wolfgang B.

Country
Germany
Department
2607: Pneumologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
63
Sites with multiple studies

Has run more than one trial at 63 of 220 partner sites.

Specializations

Advanced Lung Cancer

The investigator specializes in treating advanced non-small cell lung cancer (NSCLC), with particular emphasis on cases involving EGFR mutations and various biomarker expressions.

  • Metastatic NSCLC management
  • EGFR mutation targeted therapies
  • Biomarker-driven treatment approaches

Expertise extends to evaluating novel therapeutic combinations for patients with advanced disease stages.

Immunotherapy Innovation

Focus on developing innovative immunotherapy approaches for lung cancer treatment, particularly exploring combinations with chemotherapy and evaluating new immunotherapeutic agents.

  • PD-L1 targeted treatments
  • Combination therapy strategies
  • Novel immunotherapy agents

Specialized interest in immunotherapy outcomes for patients with varying PD-L1 expression levels.

Small Cell Lung Cancer

Dedicated research in limited-stage small cell lung cancer (LS-SCLC) treatment, incorporating multimodal therapy approaches combining immunotherapy with standard treatments.

  • Combined modality treatments
  • Radiotherapy integration
  • Early-stage disease management

Expertise in coordinating concurrent therapeutic approaches for optimal patient outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.